Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation Research
Search: search_blue_button Advanced Search
Circulation Research. 2007;101:166-175
Published online before print June 7, 2007, doi: 10.1161/CIRCRESAHA.107.155721
Free Article
This Article
Free upon publication Free Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Data Supplement
Right arrow All Versions of this Article:
101/2/166    most recent
CIRCRESAHA.107.155721v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Cingolani, E.
Right arrow Articles by Marbán, E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Cingolani, E.
Right arrow Articles by Marbán, E.
Right arrowPubmed/NCBI databases
Medline Plus Health Information
*Genes and Gene Therapy
Related Collections
Right arrow Calcium cycling/excitation-contraction coupling
Right arrow Hypertrophy
Right arrow Gene therapy
(Circulation Research. 2007;101:166.)
© 2007 American Heart Association, Inc.


Cellular Biology

Gene Therapy to Inhibit the Calcium Channel ß Subunit

Physiological Consequences and Pathophysiological Effects in Models of Cardiac Hypertrophy

Eugenio Cingolani, Genaro A. Ramirez Correa, Eddy Kizana, Mitsushige Murata, Hee Cheol Cho, Eduardo Marbán

From the Division of Cardiology (E.C., G.A.R.C., E.K., M.M., H.C.C., E.M.), Johns Hopkins University School of Medicine, Baltimore, Md.

Correspondence to Eduardo Marbán, MD, PhD, 858 Ross Building, 720 Rutland Avenue. Baltimore, MD 21205. E-mail marban{at}jhmi.edu

Calcium cycling figures prominently in excitation-contraction coupling and in various signaling cascades involved in the development of left ventricular hypertrophy. We hypothesized that genetic suppression of the L-type calcium channel accessory ß-subunit would modulate calcium current and suppress cardiac hypertrophy. A short hairpin RNA template sequence capable of mediating the knockdown of the L-type calcium channel accessory ß-subunit gene was incorporated into a lentiviral vector (PPT.CG.H1.ß2). Transduction of ventricular myocytes in vivo with the active short hairpin RNA partially inhibited the L-type calcium current. In neonatal rat cardiomyocytes, L-type calcium channel accessory ß-subunit gene knockdown reduced calcium transient amplitude. Similarly, [3H]leucine incorporation was attenuated in PPT.CG.H1.ß2-transduced neonatal rat cardiomyocytes compared with nonsilencing controls in a phenylephrine-induced hypertrophy model. In vivo gene transfer attenuated the hypertrophic response in an aortic-banded rat model of left ventricular hypertrophy, with reduced left ventricular wall thickness and heart weight/body weight ratios in PPT.CG.H1.ß2-injected rats at four weeks post transduction. Fractional shortening was preserved in rats treated with PPT.CG.H1.ß2. These findings indicate that knockdown of L-type calcium channel accessory ß-subunit is capable of attenuating the hypertrophic response both in vitro and in vivo without compromising systolic performance. Suppression of the calcium channel ß subunit may represent a novel and useful therapeutic strategy for left ventricular hypertrophy.


Key Words: hypertrophy • calcium • gene therapy




This article has been cited by other articles:


Home page
Cardiovasc ResHome page
N. Beetz, L. Hein, J. Meszaros, R. Gilsbach, F. Barreto, M. Meissner, U. C. Hoppe, A. Schwartz, S. Herzig, and J. Matthes
Transgenic simulation of human heart failure-like L-type Ca2+-channels: implications for fibrosis and heart rate in mice
Cardiovasc Res, December 1, 2009; 84(3): 396 - 406.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
C.-S. Chiang, C.-H. Huang, H. Chieng, Y.-T. Chang, D. Chang, J.-J. Chen, Y.-C. Chen, Y.-H. Chen, H.-S. Shin, K. P. Campbell, et al.
The CaV3.2 T-Type Ca2+ Channel Is Required for Pressure Overload-Induced Cardiac Hypertrophy in Mice
Circ. Res., February 27, 2009; 104(4): 522 - 530.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
S. Telemaque, S. Sonkusare, T. Grain, S. W. Rhee, J. R. Stimers, N. J. Rusch, and J. D. Marsh
Design of Mutant {beta}2 Subunits as Decoy Molecules to Reduce the Expression of Functional Ca2+ Channels in Cardiac Cells
J. Pharmacol. Exp. Ther., April 1, 2008; 325(1): 37 - 46.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
H. Wang, M. J. Kohr, D. G. Wheeler, and M. T. Ziolo
Endothelial nitric oxide synthase decreases {beta}-adrenergic responsiveness via inhibition of the L-type Ca2+ current
Am J Physiol Heart Circ Physiol, March 1, 2008; 294(3): H1473 - H1480.
[Abstract] [Full Text] [PDF]